Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 05, 2020 08:30 ET | Source: MeiraGTx

MeiraGTx Expands Leadership Team with Appointment of Robert K. Zeldin, M.D. as Chief Medical Officer

LONDON and NEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the appointment...
July 17, 2020 07:30 ET | Source: MeiraGTx

MeiraGTx Announces Positive Clinical Data Demonstrating Treatment with AAV-RPGR Investigational Gene Therapy Improves Vision in X-Linked Retinitis Pigmentosa Patients

• Data being presented at the American Society of Retina Specialists (ASRS) 2020 Virtual Annual Meeting • Significant improvements demonstrated after treatment in Phase 1/2 clinical trial • Based...
May 26, 2020 08:30 ET | Source: MeiraGTx

MeiraGTx Announces Move to Virtual-Only Format for 2020 Annual General Meeting of Shareholders

LONDON and NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that its 2020...
May 07, 2020 16:30 ET | Source: MeiraGTx

MeiraGTx Reports First Quarter 2020 Financial Results

LONDON and NEW YORK, May 07, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results...
May 06, 2020 16:30 ET | Source: MeiraGTx

MeiraGTx to Present at the Virtual Bank of America Securities 2020 Health Care Conference

LONDON and NEW YORK, May 06, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria...
March 11, 2020 17:00 ET | Source: MeiraGTx

MeiraGTx Reports Full Year 2019 Financial Results

LONDON and NEW YORK, March 11, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial...
March 02, 2020 08:30 ET | Source: MeiraGTx

MeiraGTx Announces Priority Medicines (PRIME) and Advanced Therapy Medicinal Product (ATMP) Designations Granted by the European Medicines Agency to AAV-RPGR Gene Therapy for the Treatment of X-Linked Retinitis Pigmentosa

PRIME designation granted based on clinical data from ongoing Phase 1/2 trial of AAV-RPGRAAV-RPGR is the only XLRP treatment in development to be awarded PRIME designation ...
February 24, 2020 16:30 ET | Source: MeiraGTx

MeiraGTx to Present at Upcoming Investor Conferences

LONDON and NEW YORK, Feb. 24, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes,...
December 05, 2019 16:30 ET | Source: MeiraGTx

MeiraGTx to Host Parkinson’s Disease R&D Day in New York

LONDON and NEW YORK, Dec. 05, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage gene therapy company, today announced it will host a...
November 26, 2019 16:30 ET | Source: MeiraGTx

MeiraGTx to Present at Upcoming Healthcare Conferences

LONDON and NEW YORK, Nov. 26, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria...